These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21824074)

  • 1. Insulin resistance and diabetes in HIV infection.
    Das S
    Recent Pat Antiinfect Drug Discov; 2011 Sep; 6(3):260-8. PubMed ID: 21824074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of glucose metabolism in patients infected with human immunodeficiency virus.
    Dubé MP
    Clin Infect Dis; 2000 Dec; 31(6):1467-75. PubMed ID: 11096014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.
    Brown TT; Li X; Cole SR; Kingsley LA; Palella FJ; Riddler SA; Chmiel JS; Visscher BR; Margolick JB; Dobs AS
    AIDS; 2005 Sep; 19(13):1375-83. PubMed ID: 16103768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic complications associated with antiretroviral therapy.
    Jain RG; Furfine ES; Pedneault L; White AJ; Lenhard JM
    Antiviral Res; 2001 Sep; 51(3):151-77. PubMed ID: 11448728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection.
    Paik IJ; Kotler DP
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):469-78. PubMed ID: 21663840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and HIV infection: a review.
    Aboud M; Elgalib A; Kulasegaram R; Peters B
    Int J Clin Pract; 2007 Mar; 61(3):463-72. PubMed ID: 17313615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.
    Lee GA; Rao MN; Grunfeld C
    Curr HIV/AIDS Rep; 2005 Feb; 2(1):39-50. PubMed ID: 16091248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glucose metabolism among older men with or at risk of HIV infection.
    Howard AA; Floris-Moore M; Lo Y; Arnsten JH; Fleischer N; Klein RS
    HIV Med; 2006 Sep; 7(6):389-96. PubMed ID: 16903984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study.
    d'Ettorre G; Ceccarelli G; Zaccarelli M; Ascoli-Bartoli T; Bianchi L; Bellelli V; De Girolamo G; Serafino S; Giustini N; Mastroianni CM; Vullo V
    Int J STD AIDS; 2016 Jul; 27(8):638-43. PubMed ID: 26068963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting to the HAART of insulin resistance.
    Nolan D; Mallal S
    AIDS; 2001 Oct; 15(15):2037-41. PubMed ID: 11600834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic disturbances associated with HAART].
    Olczak A
    Przegl Epidemiol; 2007; 61(4):639-46. PubMed ID: 18572495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AACTG recommendations for metabolic problems. Guide covers insulin resistance and diabetes.
    AIDS Alert; 2003 Jan; 18(1):6. PubMed ID: 12541993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance in treated HIV infection.
    Feeney ER; Mallon PW
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):443-58. PubMed ID: 21663838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women.
    Danoff A; Shi Q; Justman J; Mulligan K; Hessol N; Robison E; Lu D; Williams T; Wichienkuer P; Anastos K;
    J Acquir Immune Defic Syndr; 2005 May; 39(1):55-62. PubMed ID: 15851914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients.
    Florescu D; Kotler DP
    Antivir Ther; 2007; 12(2):149-62. PubMed ID: 17503657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.